Journal List > Ann Lab Med > v.46(3) > 1516095223

Morita, Yoshida, Yokoyama, Nakatsuka, Hisasue, Tanaka, Ono, Shukuya, and Kurano: Machine Learning-Based Analysis of UF-5000 Scattergrams Improves the Identification of Urinary Dysmorphic Red Blood Cells

Abstract

Background

Identifying dysmorphic red blood cells (RBCs) is critical for diagnosing glomerular diseases, as distinguishing glomerular from non-glomerular hematuria may reduce reliance on invasive diagnostics such as kidney biopsy. We aimed to enhance urinary RBC morphological classification by employing machine learning (ML) to analyze UF-5000 scattergram data.

Methods

RBCs in urine samples (N=185) were classified as dysmorphic or isomorphic based on microscopic findings. UF-5000 scattergrams were quantified to generate 20 statistical features and used to train a ML model in DataRobot (v9.1) with an automated pipeline, five-fold cross-validation, and LogLoss-based selection. Performance was evaluated in an independent cohort (N=1,093). Accuracy was defined as concordance with microscopy findings. Areas under ROC curves (AUROCs) and diagnostic metrics are reported with 95% confidence intervals (CIs).

Results

Among conventional UF-5000 parameters, the small RBC/total RBC ratio was the strongest predictor (AUROC 0.97, 95% CI 0.94–0.99). Scattergram-derived features indicated that RBC size-related parameters were crucial for identifying dysmorphic RBCs. The ML model alone demonstrated superior accuracy over UF-5000 RBC-Info alone (concordance 95.2% vs. 92.1%; AUROC 0.95 [0.94–0.97] vs. 0.92 [0.91–0.94]). Logical (OR/AND) combinations of the ML model with RBC-Info outperformed RBC-Info alone (OR concordance 92.7%, AUROC 0.93 [0.92–0.95]; AND concordance 94.6%, AUROC 0.94 [0.93–0.96]).

Conclusions

A scattergram-based ML model improves the accuracy and reliability of urinary RBC morphological classification based on UF-5000 scattergrams and may help reduce reliance on invasive diagnostics. Prospective, multicenter studies should validate generalizability and assess integration into routine workflows.

INTRODUCTION

Hematuria, defined as the presence of red blood cells (RBCs) in the urine, is an essential clinical finding associated with various renal and urological conditions [1, 2]. RBC morphology is a crucial diagnostic tool for differentiating between glomerular and non-glomerular hematuria [3, 4]. Glomerular hematuria is often associated with conditions such as glomerulonephritis, whereas non-glomerular hematuria typically arises from lower urinary tract disorders, including infections, malignancies, and calculi. Traditionally, RBC morphology assessment relies on manual microscopy, classifying RBCs as either isomorphic or dysmorphic. However, this method is labor-intensive, operator-dependent, and is subject to interobserver variability, leading to inconsistencies in the classification accuracy.
To overcome these limitations, automated systems, such as the Fully Automated Urine Particle Analyzer UF-5000, have been developed. Based on flow cytometry, this analyzer generates scattergram data that provide insights into the size, shape, and internal composition of urinary particles. Unlike imaging-based systems, scattergram data suggest particle characteristics based on computational analysis. However, few studies have explored the clinical applications of scattergram data.
Urinary RBC size and volume are critical markers for distinguishing glomerular from non-glomerular hematuria using automated analyzers [511]. RBC distribution and scattergram-based indices—particularly small RBC fractions—provide clinically useful discrimination against microscopic reference standards. While the UF-5000 analyzer can distinguish RBCs based on size and related characteristics using the RBC-Info feature and additionally provides built-in research parameters (e.g., small RBCs, large RBCs, lysed RBCs, non-lysed RBCs) [1215], performance can vary across settings and may be limited by specimen characteristics, underscoring the need for robust validation.
Machine learning (ML) has emerged as a promising tool for enhancing diagnostic accuracy in medical applications in recent years [1618]. By applying ML algorithms to UF-5000 scattergram data, complex patterns and features can be extracted, which may not be readily apparent using traditional diagnostic methods or human analysis. We aimed to improve urinary RBC morphology classification by utilizing ML models for scattergram analysis.
Accurately distinguishing between glomerular and non-glomerular RBCs using an ML-enhanced automated approach may have significant clinical implications. Such a system could facilitate faster and more reliable diagnoses of kidney and urinary tract diseases than existing systems, serving as a complementary tool to kidney biopsy. Additionally, these advancements may contribute to the standardization of urinary RBC morphological analysis. We assessed the integration of ML with UF-5000 scattergram data to address the existing challenges in urinary RBC morphology evaluation, laying a foundation for future innovations in renal and urological diagnostics.

MATERIALS AND METHODS

Samples

Urinalysis results from 648 ambulatory and hospitalized patients at The University of Tokyo Hospital (Tokyo, Japan) between August and October 2021 were randomly collected for this retrospective study. All urine samples were immediately analyzed using an UF-5000 instrument (Sysmex Corp., Kobe, Japan) and manual microscopy. Based on morphology, the RBCs in the samples were categorized as either dysmorphic or isomorphic, following the criteria outlined in Fig. 1. Ultimately, 185 samples were included in the analysis. Supplemental Data Table S1 presents the characteristics of the participants for the training set.
An independent validation dataset comprising 1,093 consecutive urinalysis results was collected at our institution between November 2023 and March 2024, using the same inclusion criteria as those used for the training set. These samples were entirely independent of the training dataset and were included without preselection to reflect routine clinical testing conditions. All samples were analyzed using the UF-5000 analyzer and manual microscopy. Scattergram data were obtained under the same conditions as those used for the ML model development. Supplemental Data Table S2 presents the characteristics of the participants for the validation set.

Manual microscopic examination

Four certified medical technologists specializing in urinalysis performed manual microscopic examinations according to the Japanese Committee for Clinical Laboratory Standards (JCCLS) [19]. Ten milliliters of urine was centrifuged at 500×g for 5 min, and the supernatant was decanted. The sediment (approximately 0.2 mL) was thoroughly resuspended, and 15 μL was transferred onto a glass slide and covered with an 18×18-mm cover glass. Urinary RBCs were classified as either isomorphic or dysmorphic. Dysmorphic RBCs were further categorized into three levels—minority, moderate, and majority—based on their proportions, as recommended by the JCCLS guidelines. The criteria are outlined in the Supplemental Data Table S3.

Quantification of UF-5000 scattergram data

UF-5000 employs flow cytometry with a blue semiconductor laser to detect urine sediment components using forward-scattered light, side-scattered light, side fluorescence, and depolarized side-scattered light. Urinary RBCs were identified on scattergrams, in which using depolarized side-scatter (X-axis, reflecting birefringence) is plotted against forward scatter (Y-axis, reflecting particle size). Representative microscopic and scattergram images for isomorphic and dysmorphic hematuria are shown in Supplemental Data Fig. S1.
The UF-5000 RBC-Info feature categorizes RBCs as “Isomorphic,” “Mixed,” or “Dysmorphic” based on RBC-P70Fsc (forward scatter, Fsc) and RBC-Fsc-DW (distribution width, DW). RBC-P70Fsc is defined as the 70th percentile of the forward-scatter signal intensity of RBC events, and RBC-Fsc-DW as the distribution width of the RBC forward-scatter signal. Additional parameters included the counts of small, large, lysed, and non-lysed RBCs, which are automatically categorized and output by the UF-5000 analyzer based on internal scattergram analysis algorithms, using manufacturer-defined thresholds. Various ratios of each RBC subtype (e.g., small RBC/total RBC ratio) were manually calculated from the absolute counts provided by the UF-5000 instrument.
Scattergram images were imported into ImageJ 1.54 (NIH, Bethesda, MD, USA) for feature extraction, including minimum and maximum values, mean, standard deviation, median, skewness, and kurtosis for both axes. Regression equation parameters (slope, intercept, and coefficient of determination) were also computed.

ML model development

To construct a predictive model for RBC morphology classification, we used DataRobot (v9.1, https://www.datarobot.com/), an automated ML platform. The platform explored multiple algorithm families, including logistic regression and elastic net, random forests, gradient boosting (LightGBM), XGBoost, support vector machines, k-nearest neighbors, and shallow neural networks. Model selection was based on the logarithmic loss (LogLoss) metric, which evaluates the classification probability accuracy. Cross-validation was performed automatically in DataRobot using a five-fold strategy to assess generalizability and to avoid overfitting. Hyperparameters were tuned internally using the built-in optimization routines of DataRobot, which apply techniques such as grid search or Bayesian optimization, depending on the model type and data characteristics.

Statistical analysis

To facilitate comparisons between UF-5000 and manual microscopy results, urinary RBC counts were converted using the formula particles (p)/high-power field=0.18×p/µL. Statistical analyses were conducted using EZR (Easy R, v1.68) [20]. Cochran’s Q test was used to assess the differences in concordance rates across more than two classifiers, and post-hoc pairwise comparisons were performed using McNemar’s test (exact version when discordant counts were small), with Holm–Bonferroni adjustment as applicable. For two-classifier comparisons of concordance rates, McNemar’s test alone was used. The Mann–Whitney U-test was used to compare variables among groups. ROC curve analysis was performed using StatFlex (v6.0) to evaluate the diagnostic performance of the UF-5000 parameters in distinguishing RBC morphology. Statistical significance was set to P<0.05.

RESULTS

The small RBC/total RBC ratio as a key indicator

The small RBC/total RBC ratio showed the highest accuracy, achieving an area under the ROC curve (AUROC) of 0.97 (Table 1). Fig. 2 illustrates ROC curves and cutoff values for the small RBC/total RBC ratio, RBC-P70-Fsc, and RBC-Fsc-DW. Compared with RBC-Info, the small RBC/total RBC ratio demonstrated superior accuracy in RBC morphology classification in terms of the concordance rate (94.1% vs. 88.1%), AUROC (0.97 vs. 0.88), sensitivity (93.2% vs. 86.3%), specificity (94.6% vs. 89.3%), positive predictive value (PPV; 91.9% vs. 84.0%), negative predictive value (NPV; 95.5% vs. 90.9%), positive likelihood ratio (PLR; 17.39 vs. 8.06), and negative likelihood ratio (NLR; 0.07 vs. 0.15) (Table 2).

Scattergram data analysis and RBC size parameters

Supplemental Data Table S4 presents a comparison of variables derived from the quantification of UF-5000 scattergram data between samples with dysmorphic and isomorphic RBCs. X-axis skewness and kurtosis (1.50 vs. 1.10, P=0.005; 6.10 vs. 3.15, P=0.005, respectively) and Y-axis skewness (0.10 vs. –0.80, P<0.001) were significantly greater in the dysmorphic RBC group than in the isomorphic RBC group. Conversely, the minimum and maximum values, mean, median, and kurtosis of the Y-axis (17.00 vs. 19.00, 174.00 vs. 186.50, 85.00 vs. 125.15, 85.50 vs. 135.00, and –0.60 vs. 0.25, respectively) and the intercept of the regression equation (80.80 vs. 126.25) were lower in the dysmorphic RBC group than in the isomorphic RBC group, with P<0.001 for all comparisons.

High concordance rate of the ML model

To improve RBC morphology classification further, we developed an ML model using the DataRobot. The model was trained using 20 quantitative features extracted via scattergram analysis (Supplemental Data Table S4). These features reflect the geometric and statistical properties of RBC distribution patterns across the scattergram axes, including conventional histogram descriptors (e.g., minimum, maximum, and median) and higher-order statistical features, such as skewness and kurtosis along the X- and Y-axes. No clinical or demographic variables (Table 1) were included in the model input. During model generation, 70 candidate models were automatically generated. The model labeled “Light Gradient Boosting on ElasticNet Predictions” achieved the best performance, with a LogLoss of 0.207 (Supplemental Data Fig. S2A), and was selected for further evaluations. Feature impact analysis showed that the Y-axis median (Y-median) was the most influential variable, followed by Y-skewness and Y-minimum, suggesting that the vertical distribution patterns of RBCs in the scattergram were key determinants in the ML-based classification (Supplemental Data Fig. S2B). When validated against manual microscopic examination, the ML model achieved a concordance rate of 93.9%, sensitivity of 94.9%, specificity of 93.3%, and AUROC of 0.95.
To assess its performance further, the ML model was tested on an independent dataset comprising 1,093 samples with both manual microscopic examination results and RBC-Info data. Among RBC-Info outputs labeled as “Mixed” or “Dysmorphic”, we reclassified all the “Mixed” and “Dysmorphic” cases as “Dysmorphic” because 88.6% of the samples were classified as “Dysmorphic” by microscopy. Notably, “Mixed” is considered suggestive of dysmorphic RBCs, and manual confirmation is generally recommended. Although this reclassification may have introduced interpretive bias, it was conducted to reflect predominant manual findings and maintain consistency in the subgroup analysis. The model demonstrated improved classification accuracy compared with RBC-Info, achieving a concordance rate of 95.2% vs. 92.1% and an AUROC of 0.95 (0.94–0.97) vs. 0.92 (0.91–0.94) (Table 3). Although the ML model had lower sensitivity (94.4% [92.0–96.3]) than RBC-Info (95.0% [92.7–96.7]), other parameters were improved, with a specificity of 95.9% (94.0–97.4) vs. 89.7% (87.0–92.0), PPV of 95.2% (92.9–96.9) vs. 88.6% (85.6–91.2), and PLR of 23.29 (15.73–34.48) vs. 9.22 (7.26–11.70).

Effects of combining the ML model with RBC-Info on RBC classification performance

To determine whether integrating RBC-Info with the ML model would improve classification accuracy, we conducted a simulation using DataRobot. When evaluated against manual microscopic examination, logical OR/AND combinations of the ML model and RBC-Info outperformed RBC-Info alone (concordance rates: 92.7% and 94.6%; AUROC: 0.93 [0.92–0.95] and 0.94 [0.93–0.96], respectively) (Table 3).

Model performance across RBC morphology subgroups

To evaluate model performance based on the degree of dysmorphic RBC representation, we stratified the cases into four subgroups based on the proportion of urinary RBCs in manual microscopy: isomorphic, dysmorphic-minority, dysmorphic-moderate, and dysmorphic-majority. As shown in Fig. 3A, the concordance rates between the ML model and manual classification were 95.9%, 88.8%, 98.9%, and 93.3% in the isomorphic (568/592), dysmorphic-minority (190/214), dysmorphic-moderate (269/272), and dysmorphic-majority groups (14/15), respectively.
Although the overall model performance was high, the lower concordance in the dysmorphic-minority group suggests a need for further improvement of the system for samples with a small proportion of dysmorphic RBCs. A comparative analysis of scattergram-derived parameters between the concordant and discordant groups classified by the ML model relative to manual microscopic examination is provided in Supplemental Data Table S5. To explore the underlying reasons for misclassification, we analyzed the key features used by the model (i.e., Y-median, Y-skewness, and Y-minimum) in matched versus mismatched samples. As shown in Fig. 3B–D, mismatched cases in both the isomorphic and dysmorphic-minority groups displayed significantly different values from matched cases, with the mismatched dysmorphic-minority cases often showing feature profiles closer to those of isomorphic RBCs. In addition, representative discordant cases (Supplemental Data Fig. S3) either had a very low number of dysmorphic RBCs or exhibited overlapping morphological features with isomorphic RBCs, complicating classification.

DISCUSSION

Current assessment of urinary RBC morphology is limited by variability and interobserver differences inherent to manual microscopy. In this study, we identified three complementary solutions that improve classification accuracy: the small RBC/total RBC ratio derived from UF-5000 outputs, a set of novel scattergram-derived features, and ML algorithms built on these features. The results revealed that, together, these approaches enhance the accuracy of urinary RBC classification and may help differentiate between glomerular and non-glomerular hematuria.
First, the small RBC/total RBC ratio was the most effective parameter for distinguishing RBC morphology. Compared with RBC-Info, this ratio significantly improved classification performance across multiple metrics, including the concordance rate, sensitivity, specificity, PPV, NPV, PLR, and NLR (Table 2). These results suggest that the small RBC/total RBC ratio is a promising alternative to conventional RBC-Info for automated RBC morphological analysis using the UF-5000 analyzer. This finding aligns with those in previous studies [12, 13], reinforcing its validity as a reliable diagnostic parameter.
Second, this study represents the first quantitative analysis of UF-5000 scattergram data. Our analysis revealed that several Y-axis features, which correlated with particle size, were significantly smaller in the dysmorphic RBC group than in the isomorphic RBC group (Supplemental Data Table S3). Notably, the negative skewness along the Y-axis suggests that the histogram peak shifts toward lower values, indicating a higher concentration of smaller RBCs. Additionally, lower kurtosis in the Y-axis implies a flatter histogram peak, reflecting greater heterogeneity in RBC morphology. These findings suggest that RBC size plays a critical role in differentiating dysmorphic RBCs from isomorphic RBCs. In clinical practice, scattergram and histogram data obtained from the UF-5000 analyzer may serve as valuable adjuncts to manual microscopic examination for urinary RBC classification.
Finally, the ML model developed using DataRobot achieved a high concordance rate (93.9%) and AUROC (0.95) compared with manual microscopy. Validation using an independent dataset confirmed the model’s robustness, with a concordance rate of 95.2% and an AUROC of 0.95 (Table 3). Importantly, the ML model did not include the small RBC/total RBC ratio as an input, although this parameter has been validated as a useful screening indicator [10]. The improved performance of the ML model was achieved solely via the scattergram-derived geometric and statistical features. The combined use of both methods did not improve the overall concordance. As shown in Table 3, logical combinations, such as RBC-Info AND the ML model, improved specificity (97.1%) but decreased sensitivity (91.6%), resulting in a slightly lower concordance (94.6%) than that achieved with the ML model alone. This outcome may reflect conflicting decision boundaries between the two classifiers, and future studies should explore more sophisticated ensemble approaches. Nonetheless, these findings suggest that combining traditional parameters with ML approaches can optimize RBC morphology classification and improve the clinical utility of the UF-5000.
The reduced concordance rate in cases with a minority proportion of dysmorphic RBCs (Fig. 3) indicates that further refinement of the system is needed to enhance its accuracy for this subgroup. As shown in representative cases in Supplemental Data Fig. S3, some discordant samples exhibited either a very low number of dysmorphic RBCs or a mixture of dysmorphic and isomorphic morphological features on scattergram analysis, which likely contributed to the classification difficulty. Although quantitative parameters, such as Y-median and Y-skewness, were useful overall, these features alone were insufficient to reliably distinguish minority-type dysmorphic RBCs from isomorphic RBCs (Fig. 3B–D and Supplemental Data Table S5). To overcome this limitation, future efforts should focus on developing a dedicated secondary classifier tailored to detect subtle glomerular features or identify novel features better suited for borderline cases.
Notably, the ML model developed in this study was based on UF-5000-specific output parameters. However, the model is not generalizable to data from other urine analyzers. Nevertheless, the analytical methodology itself remains broadly applicable and may be adapted to other platforms with similar data structures, pending appropriate calibration and validation.
This study had two key limitations. First, it was conducted as a single-center, retrospective analysis, which limits the generalizability of the proposed ML model. Further validation across multiple institutions and in prospective settings is warranted. Second, the correlation between RBC morphological assessments derived from urine sediment analysis and histological diagnoses was incomplete. Some samples lacked a definitive etiological classification for hematuria. However, as biopsies are invasive and not routinely performed in most patients, microscopic examination remains the most practical method in clinical laboratories. Future studies should evaluate the proposed algorithm using patient data with histological diagnoses to strengthen its clinical applicability.
In conclusion, the scattergram data-based ML model significantly improves the reliability and accuracy of urinary RBC morphological evaluation using the UF-5000. These methods have the potential to standardize urinary RBC classification and serve as valuable tools for diagnosing and monitoring renal and urological diseases. By improving classification, they may reduce unnecessary kidney biopsies, enable earlier differentiation between glomerular and non-glomerular hematuria, and support more standardized, faster decision-making in nephrology and urology practice, thereby linking model outputs more directly to patient management.

ACKNOWLEDGEMENTS

None.

Notes

AUTHOR CONTRIBUTIONS

Morita Y conceptualized the study, was responsible for methodology, data visualization, funding acquisition, and project administration, and wrote the original draft; Yokoyama R, Nakatsuka N, Hisasue T, and Tanaka M performed the investigation; Kurano M supervised the study; Yoshida T, Ono Y, Shukuya K, and Kurano M reviewed and edited the manuscript. All authors read and approved the final manuscript.

CONFLICTS OF INTEREST

None declared.

RESEARCH FUNDING

This study was supported by Sysmex Corporation.

Appendix

SUPPLEMENTARY MATERIALS

Supplementary materials can be found via https://doi.org/10.3343/alm.2025.0227.

REFERENCES

1. Cohen RA, Brown RS. 2003; Clinical practice. Microscopic hematuria. N Engl J Med. 348:2330–8. DOI: 10.1056/NEJMcp012694. PMID: 12788998.
2. Vedula R, Iyengar AA. 2020; Approach to diagnosis and management of hematuria. Indian J Pediatr. 87:618–24. DOI: 10.1007/s12098-020-03184-4. PMID: 32026313.
3. Saha MK, Massicotte-Azarniouch D, Reynolds ML, Mottl AK, Falk RJ, Jennette JC, et al. 2022; Glomerular hematuria and the utility of urine microscopy: A review. Am J Kidney Dis. 80:383–92. DOI: 10.1053/j.ajkd.2022.02.022. PMID: 35777984.
4. Fogazzi GB, Ponticelli C. 1996; Microscopic hematuria diagnosis and management. Nephron. 72:125–34. DOI: 10.1159/000188830. PMID: 8684515.
5. Lettgen B, Hestermann C, Rascher W. 1994; Differentiation of glomerular and non-glomerular hematuria in children by measurement of mean corpuscular volume of urinary red cells using a semi-automated cell counter. Acta Paediatr. 83:946–9. DOI: 10.1111/j.1651-2227.1994.tb13178.x. PMID: 7819692.
6. Angulo JC, Lopez-Rubio M, Guil M, Herrero B, Burgaleta C, Sanchez-Chapado M. 1999; The value of comparative volumetric analysis of urinary and blood erythrocytes to localize the source of hematuria. J Urol. 162:119–26. DOI: 10.1097/00005392-199907000-00028. PMID: 10379753.
7. Birch DF, Fairley KF, Whitworth JA, Forbes I, Fairley JK, Cheshire GR, et al. 1983; Urinary erythrocyte morphology in the diagnosis of glomerular hematuria. Clin Nephrol. 20:78–84. PMID: 6616978.
8. Offringa M, Benbassat J. 1992; The value of urinary red cell shape in the diagnosis of glomerular and post-glomerular haematuria. A meta-analysis. Postgrad Med J. 68:648–54. DOI: 10.1136/pgmj.68.802.648. PMID: 1448406. PMCID: PMC2399558.
9. Hyodo T, Kumano K, Sakai T. 1999; Differential diagnosis between glomerular and nonglomerular hematuria by automated urinary flow cytometer. Kitasato University Kidney Center criteria. Nephron. 82:312–23. DOI: 10.1159/000045446. PMID: 10450033.
10. Kim H, Kim YO, Kim Y, Suh JS, Cho EJ, Lee HK. 2019; Small red blood cell fraction on the UF-1000i urine analyzer as a screening tool to detect dysmorphic red blood cells for diagnosing glomerulonephritis. Ann Lab Med. 39:271–7. DOI: 10.3343/alm.2019.39.3.271. PMID: 30623619. PMCID: PMC6340839.
11. Yang WS. 2021; Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases. Sci Rep. 11:20981. DOI: 10.1038/s41598-021-00457-6. PMID: 34697364. PMCID: PMC8546052. PMID: 9d6a88e199904083a133048161f9924a.
12. Mizuno G, Hoshi M, Nakamoto K, Sakurai M, Nagashima K, Fujita T, et al. 2021; Evaluation of red blood cell parameters provided by the UF-5000 urine auto-analyzer in patients with glomerulonephritis. Clin Chem Lab Med. 59:1547–53. DOI: 10.1515/cclm-2021-0287. PMID: 33908221.
13. Cho H, Yoo J, Kim H, Jang H, Kim Y, Chae H. 2022; Diagnostic characteristics of urinary red blood cell distribution incorporated in UF-5000 for differentiation of glomerular and non-glomerular hematuria. Ann Lab Med. 42:160–8. DOI: 10.3343/alm.2022.42.2.160. PMID: 34635609. PMCID: PMC8548254.
14. Lee AJ, Bang HI, Lee SM, Won D, Kang MS, Choi HJ, et al. 2025; Comparison of urinary red blood cell distribution (URD) and dysmorphic red blood cells for detecting glomerular hematuria: A multicenter study. J Clin Lab Anal. 39:e25159. DOI: 10.1002/jcla.25159. PMID: 39895569. PMCID: PMC11904819.
15. Lv S, Fang Y, Hu X, Zhang J, Lou X, Chen C, et al. 2025; UF-5000 urinary erythrocyte parameters versus urinary aberrant erythrocytes and acanthocytes for diagnosing IgA glomerular hematuria. Sci Rep. 15:1157. DOI: 10.1038/s41598-025-85575-1. PMID: 39774763. PMCID: PMC11707189. PMID: 83813b73690e4ceeb6cc4ac8e48fef1d.
16. De Bruyne S, Speeckaert MM, Van Biesen W, Delanghe JR. 2021; Recent evolutions of machine learning applications in clinical laboratory medicine. Crit Rev Clin Lab Sci. 58:131–52. DOI: 10.1080/10408363.2020.1828811. PMID: 33045173.
17. Herman DS, Rhoads DD, Schulz WL, Durant TJS. 2021; Artificial intelligence and mapping a new direction in laboratory medicine: a review. Clin Chem. 67:1466–82. DOI: 10.1093/clinchem/hvab165. PMID: 34557917.
18. Hou H, Zhang R, Li J. 2024; Artificial intelligence in the clinical laboratory. Clin Chim Acta. 559:119724. DOI: 10.1016/j.cca.2024.119724. PMID: 38734225.
19. Japanese Association of Medical Technologists and Editorial Committee of the Special Issue: Urinary Sediment. 2017; Aims of the guidelines on urinary sediment examination procedures proposed by the Japanese Committee for Clinical Laboratory Standards (JCCLS). Jpn J Med Technol. 66(J-STAGE-1):9–17. https://www.jstage.jst.go.jp/article/jamt/66/J-STAGE-1/66_17J1-1/_html/-char/en. Accessed on Sept 24, 2025. PMID: https://www.jstage.jst.go.jp/article/jamt/66/J-STAGE-1/66_17J1-1/_html/-char/en.
20. Kanda Y. 2013; Investigation of the freely available easy-to-use software "EZR" for medical statistics. Bone Marrow Transplant. 48:452–8. DOI: 10.1038/bmt.2012.244. PMID: 23208313. PMCID: PMC3590441.

Fig. 1
Flowchart of study participant recruitment. Of 648 urine sediment tests, 407 with <5 RBCs/HPF were excluded. Among 241 with ≥5 RBCs/HPF, 32 were not classified by UF-5000, six had RBC counts mismatched with those obtained through manual microscopy, and 18 were not classifiable using manual microscopy, leaving 185 for validation.
Abbreviations: HPF, high-power field; RBC, red blood cell.
alm-46-3-270-f1.tif
Fig. 2
ROC curve analysis of the small RBC/total RBC ratio. Comparison of AUROCs for the small RBC/total RBC ratio (closed red circles), RBC-P70Fsc (open circles), and RBC-Fsc-DW (open diamonds) in RBC morphology. Cutoff values were determined using the Youden index. Units: Fsc intensity in (ch), an instrument-specific arbitrary unit.
Abbreviations: AUROC, area under the ROC curve; CI, confidence interval; ch, channels; DW, distribution width; Fsc, forward scatter; RBC, red blood cell.
alm-46-3-270-f2.tif
Fig. 3
Concordance of the ML model with manual microscopic examination and subgroup comparison. (A) Concordance rates across subgroups (N, %), comparing ML model classification results with manual classification results. Mismatched cases are represented in black. (B–D) Comparative analysis of scattergram-derived parameters, i.e., y-Median (B), y-Skewness (C), and y-Minimum (D), between concordant and discordant classifications within the isomorphic and dysmorphic-minority RBC groups. Continuous parameters in panels B–D were compared using the Mann–Whitney U-test. Exact P-values are displayed in each panel.
Abbreviations: ML, machine learning; RBC, red blood cell.
alm-46-3-270-f3.tif
Table 1
Performance of UF-5000 parameters in distinguishing RBC morphology
Parameter AUC (95% CI) P Log2(fold change)*
Small RBC/total RBC ratio 0.97 (0.94–0.99) <0.001 –2.52
Large RBC/small RBC ratio 0.96 (0.93–0.99) <0.001 5.87
Small RBC/non-lysed RBC ratio 0.96 (0.93–0.99) <0.001 –2.51
Large RBC/non-lysed RBC ratio 0.96 (0.93–0.99) <0.001 1.15
Large RBC/total RBC ratio 0.96 (0.93–0.99) <0.001 1.17
RBC-P70Fsc 0.95 (0.92–0.99) <0.001 0.59
RBC-Fsc-DW 0.90 (0.85–0.95) <0.001 –0.82
Large RBC 0.89 (0.84–0.94) <0.001 4.69
RBC count 0.81 (0.75–0.88) <0.001 3.57
Non-lysed RBCs 0.81 (0.75–0.88) <0.001 3.60
Non-lysed RBC/total RBC ratio 0.78 (0.72–0.85) 0.004 0.02
Lysed RBC/non-lysed RBC ratio 0.78 (0.71–0.84) <0.001 –1.02
Lysed RBC/total RBC ratio 0.78 (0.71–0.84) <0.001 –1.06
Small RBCs 0.70 (0.63–0.77) <0.001 –0.76
Lysed RBCs 0.51 (0.43–0.59) 0.934 0.46

*Log2(fold change) values represent the log2-transformed ratio of the metric between the dysmorphic and isomorphic RBC groups.

Abbreviations: AUC, area under the curve; CI, confidence interval; Fsc, forward scatter; DW, distribution width; RBC, red blood cell.

Table 2
Performance of the small RBC/total RBC ratio compared to that of manual microscopic examination in distinguishing RBC morphology*,†
Performance metrics RBC-Info vs. manual microscopy Small RBC/total RBC ratio vs. manual microscopy
Concordance rate (%) 88.1 94.1
AUROC 0.88 (0.83–0.93) 0.97 (0.94–0.99)
Sensitivity (%) 86.3 (76.2–93.2) 93.2 (84.7–97.7)
Specificity (%) 89.3 (82.0–94.3) 94.6 (88.7–98.0)
PPV (%) 84.0 (73.7–91.4) 91.9 (83.2–97.0)
NPV (%) 90.9 (83.9–95.6) 95.5 (89.8–98.5)
PLR 8.06 (4.68–13.86) 17.39 (7.96–37.97)
NLR 0.15 (0.09–0.27) 0.07 (0.03–0.17)

*McNemar’s test for the difference in concordance rate yielded P=0.015; other metrics were not subjected to inferential comparison.

Values in parentheses represent the 95% confidence interval.

Abbreviations: AUROC, area under the ROC curve; PPV, positive predictive value; NPV, negative predictive value; PLR, positive likelihood ratio; NLR, negative likelihood ratio.

Table 3
Comparison of classification performance between the ML model, RBC-Info, and their combinations*
Performance metrics RBC-Info ML model RBC-Info OR ML model RBC-Info AND ML model
Concordance rate (%) 92.1 95.2 92.7 94.6,§
AUROC 0.92 (0.91–0.94) 0.95 (0.94–0.97) 0.93 (0.92–0.95) 0.94 (0.93–0.96)
Sensitivity (%) 95.0 (92.7–96.7) 94.4 (92.0–96.3) 97.8 (96.1–98.9) 91.6 (88.8–93.9)
Specificity (%) 89.7 (87.0–92.0) 95.9 (94.0–97.4) 88.5 (85.7–91.0) 97.1 (95.4–98.3)
PPV (%) 88.6 (85.6–91.2) 95.2 (92.9–96.9) 87.8 (84.8–90.4) 96.4 (94.3–97.9)
NPV (%) 95.5 (93.4–97.1) 95.3 (93.3–96.9) 97.9 (96.4–99.0) 93.2 (90.9–95.1)
PLR 9.22 (7.26–11.70) 23.29 (15.73–34.48) 8.52 (6.81–10.65) 31.90 (19.96–51.01)
NLR 0.06 (0.04–0.08) 0.06 (0.04–0.08) 0.03 (0.01–0.05) 0.09 (0.07–0.12)

*To calculate the concordance rates, samples identified as “Mixed” or “Dysmorphic” based on RBC-Info were reclassified as “Dysmorphic” because 88.6% of the samples were classified as “Dysmorphic” by microscopy. Cochran’s Q test was used to compare concordance rates with manual microscopy (P<0.01). Post-hoc pairwise comparisons were made using McNemar’s test, with Holm–Bonferroni adjustment as applicable.

P<0.05 vs. RBC-Info

P<0.05 vs. ML model

§P<0.05 vs. RBC-Info OR ML model. Values in parentheses represent the 95% confidence interval.

Abbreviations: AUROC, area under the ROC curve; PPV, positive predictive value; NPV, negative predictive value; PLR, positive likelihood ratio; NLR, negative likelihood ratio.

TOOLS
Similar articles